{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T21:46:42Z","timestamp":1775166402909,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2018YFC1312300"],"award-info":[{"award-number":["2018YFC1312300"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971213"],"award-info":[{"award-number":["81971213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autoimmune encephalitis (AE) is a group of severe antibody-mediated brain diseases. The understanding of clinical management of AE has developed rapidly. However, the knowledge level of AE and barriers to effective treatment among neurologists remains unstudied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a questionnaire survey among neurologist in western China on knowledge of AE, treatment practices, and perspectives on barriers to treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1113 neurologists were invited and 690 neurologists from 103 hospitals completed the questionnaire with a response rate of 61.9%. Respondents correctly answered 68.3% of medical questions about AE. Some respondents (12.4%) never assayed for diagnostic antibodies if patients had suspected AE. Half (52.3%) never prescribed immunosuppressants for AE patients, while another 7.6% did not know whether they should do so. Neurologists who never prescribed immunosuppressants were more likely to have less education, a less senior job title, and to practice in a smaller setting. Neurologists who did not know whether to prescribe immunosuppressants were associated with less AE knowledge. The most frequent barrier to treatment, according to respondents, was financial cost. Other barriers to treatment included patient refusal, insufficient AE knowledge, lack of access to AE guidelines, drugs or diagnostic test, etc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Neurologists in western China lack AE knowledge. Medical education around AE is urgent needed and should be more targeted to individuals with less educated level or working in non-academic hospitals. Policies should be developed to increase the availability of AE related antibody testing or drugs and reduce the economic burden of disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-023-03139-0","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T06:03:32Z","timestamp":1678169012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Limitations on knowledge of autoimmune encephalitis and barriers to its treatment among neurologists: a survey from western China"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8630-6611","authenticated-orcid":false,"given":"Aiqing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kundian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0014-6873","authenticated-orcid":false,"given":"Zhen","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"issue":"4","key":"3139_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391\u2013404.","journal-title":"Lancet Neurol"},{"issue":"002","key":"3139_CR2","first-page":"91","volume":"050","author":"Expert consensus on","year":"2017","unstructured":"Expert consensus on. Diagnosis and treatment of autoimmune encephalitis in China. Chin J Neurol. 2017;050(002):91\u20138.","journal-title":"Chin J Neurol"},{"key":"3139_CR3","doi-asserted-by":"crossref","unstructured":"Nosadini M, Thomas T, Eyre M et al. International consensus recommendations for the treatment of pediatric NMDAR antibody encephalitis. Neurol Neuroimmunol Neuroinflamm. 2021;8(5).","DOI":"10.1212\/NXI.0000000000001052"},{"issue":"1","key":"3139_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ana.25131","volume":"83","author":"D Dubey","year":"2018","unstructured":"Dubey D, Pittock SJ, Kelly CR, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018;83(1):166\u201377.","journal-title":"Ann Neurol"},{"issue":"6","key":"3139_CR5","doi-asserted-by":"publisher","first-page":"e891","DOI":"10.1212\/NXI.0000000000000891","volume":"7","author":"A Li","year":"2020","unstructured":"Li A, Gong X, Guo K, Lin J, Hong Z. Direct economic burden of patients with autoimmune encephalitis in western China. Neurol Neuroimmunol Neuroinflamm. 2020;7(6):e891.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"3139_CR6","doi-asserted-by":"publisher","first-page":"e958","DOI":"10.1212\/NXI.0000000000000958","volume":"8","author":"X Gong","year":"2021","unstructured":"Gong X, Chen C, Liu X, et al. Long-term functional outcomes and relapse of Anti-NMDA receptor encephalitis: a cohort study in Western China. Neurol Neuroimmunol Neuroinflamm. 2021;8(2):e958.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3139_CR7","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1111\/epi.13929","volume":"58","author":"X Liu","year":"2017","unstructured":"Liu X, Yan B, Wang R, et al. Seizure outcomes in patients with anti-NMDAR encephalitis: a follow-up study. Epilepsia. 2017;58:2104\u201311.","journal-title":"Epilepsia"},{"issue":"12","key":"3139_CR8","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1212\/WNL.0b013e3182a4a49c","volume":"81","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, Mccracken L, Gabilondo I, et al. Late-onset anti\u2013NMDA receptor encephalitis. Neurology. 2013;81(12):1058\u201363.","journal-title":"Neurology"},{"issue":"19","key":"3139_CR9","doi-asserted-by":"publisher","first-page":"e2185","DOI":"10.1212\/WNL.0000000000007475","volume":"92","author":"M de Bruijn","year":"2019","unstructured":"de Bruijn M, van Sonderen A, van Coevorden-Hameete M, et al. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABAR encephalitis. Neurology. 2019;92(19):e2185\u201396.","journal-title":"Neurology"},{"issue":"1","key":"3139_CR10","doi-asserted-by":"publisher","first-page":"e633","DOI":"10.1212\/NXI.0000000000000633","volume":"7","author":"X Xu","year":"2020","unstructured":"Xu X, Lu Q, Huang Y, et al. Anti-NMDAR encephalitis: a single-center, longitudinal study in China. Neurol Neuroimmunol Neuroinflamm. 2020;7(1):e633.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"3139_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3988\/jcn.2014.10.2.157","volume":"10","author":"L Jung-Ah","year":"2014","unstructured":"Jung-Ah L, Soon-Tae L, Keun-Hwa J, et al. Anti-N-Methyl-D-Aspartate receptor encephalitis in Korea: clinical features, treatment, and outcome. J Clin Neurol. 2014;10(2):157\u201361.","journal-title":"J Clin Neurol"},{"issue":"6","key":"3139_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1053\/seiz.1999.0325","volume":"8","author":"B Tim","year":"1999","unstructured":"Tim B. Proactive pre-conception counselling for women with epilepsy\u2014is it effective? Seizure. 1999;8(6):322\u20137.","journal-title":"Seizure"},{"key":"3139_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.clineuro.2013.12.009","volume":"118","author":"J Li","year":"2014","unstructured":"Li J, Chen D, Song W, et al. Survey on general knowledge on Parkinson\u2019s disease in patients with Parkinson\u2019s disease and current clinical practice for Parkinson\u2019s disease among general neurologists from Southwest China. Clin Neurol Neurosurg. 2014;118:16\u201320.","journal-title":"Clin Neurol Neurosurg"},{"issue":"24","key":"3139_CR14","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1212\/WNL.0000000000000515","volume":"82","author":"B Roongroj","year":"2014","unstructured":"Roongroj B. Identifying gaps in knowledge about Parkinson disease among medical professionals in Thailand. Neurology. 2014;82(24):2238\u201340.","journal-title":"Neurology"},{"issue":"10","key":"3139_CR15","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1212\/WNL.0000000000003686","volume":"88","author":"A Vajda","year":"2017","unstructured":"Vajda A, Mclaughlin RL, Heverin M, et al. Genetic testing in ALS: a survey of current practices. Neurology. 2017;88(10):991\u20139.","journal-title":"Neurology"},{"issue":"3","key":"3139_CR16","first-page":"1","volume":"22","author":"YRN Alcala","year":"2019","unstructured":"Alcala YRN, Kehoe C, Shorr E, et al. Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and canadian movement disorders specialists. Genet Sci. 2019;22(3):1\u20137.","journal-title":"Genet Sci"},{"key":"3139_CR17","unstructured":"China National Bureau of Statistics. Available at: http:\/\/www.stats.gov.cn\/tjsj\/ndsj\/2021\/indexch.htm. Accessed July 22, 2021."},{"issue":"5","key":"3139_CR18","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1016\/S2214-109X(17)30100-6","volume":"5","author":"Y Gao","year":"2017","unstructured":"Gao Y, Zhou H, Singh NS, et al. Progress and challenges in maternal health in western China: a countdown to 2015 national case study. Lancet Glob Health. 2017;5(5):e523\u201336.","journal-title":"Lancet Glob Health"},{"key":"3139_CR19","doi-asserted-by":"crossref","unstructured":"Sun ZJ, Zhu L, Liang M et al. The usability of a WeChat-based electronic questionnaire for collecting participant-reported data in female pelvic floor disorders: a comparison with the traditional paper-administered format[J].Menopause-the Journal of the North American Menopause Society, 2016,23.","DOI":"10.1097\/GME.0000000000000690"},{"key":"3139_CR20","unstructured":"SO JUMP. Available at: https:\/\/www.wjx.cn\/. Accessed July 22, 2021."},{"key":"3139_CR21","first-page":"1","volume":"00","author":"X Gong","year":"2022","unstructured":"Gong X, Luo R, Liu J, et al. Efficacy and tolerability of intravenous immunoglobulin versus intravenous methylprednisolone treatment in anti-N-methyl-d-aspartate receptor encephalitis. Eur J Neurol. 2022;00:1\u201311.","journal-title":"Eur J Neurol"},{"key":"3139_CR22","doi-asserted-by":"crossref","unstructured":"Liu Y, Hao X, Zhou D et al. Relapsing and immune-responsive paroxysmal jaw clonus with blepharospasm and sialorrhea associated with D2R autoantibodies. Neurol Neuroimmunol Neuroinflamm. 2022;9(4).","DOI":"10.1212\/NXI.0000000000001172"},{"key":"3139_CR23","doi-asserted-by":"crossref","unstructured":"Liu X, Guo K, Lin J et al. Long-term seizure outcomes in patients with autoimmune encephalitis: A prospective observational registry study update.Epilepsia. 2022.","DOI":"10.1111\/epi.17245"},{"issue":"2","key":"3139_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/01376517-200504000-00005","volume":"37","author":"L Long","year":"2005","unstructured":"Long L, McAuley J, Shneker B, Moore J. The validity and reliability of the knowledge of Women\u2019s Issues and Epilepsy (KOWIE) questionnaires I and II. J Neurosci nursing: J Am Association Neurosci Nurses. 2005;37(2):88\u201391.","journal-title":"J Neurosci nursing: J Am Association Neurosci Nurses"},{"key":"3139_CR25","unstructured":"National Health Commission of the People\u2019s Republic of China. National Data-2021 [online]. Available at: http:\/\/www.nhc.gov.cn\/. Accessed July 22, 2021."},{"key":"3139_CR26","doi-asserted-by":"crossref","unstructured":"Zhou X, Pu J, Zhong X, et al. China Neurologist Association. Burnout, psychological morbidity, job stress, and job satisfaction in chinese neurologists. Neurology. 2017 May;88(2):1727\u201335.","DOI":"10.1212\/WNL.0000000000003883"},{"issue":"1","key":"3139_CR27","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12913-017-2300-6","volume":"17","author":"L Ma","year":"2017","unstructured":"Ma L, Niu X, Zhang W, et al. Assessment of neurologists\u2019 knowledge regarding intravenous fibrinolytic therapy for acute stroke in Shanxi province in China. BMC Health Serv Res. 2017;17(1):358.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"3139_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","volume":"9","author":"E Lancaster","year":"2010","unstructured":"Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9(1):67\u201376.","journal-title":"Lancet Neurol"},{"issue":"4","key":"3139_CR29","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s12160-016-9798-4","volume":"50","author":"ME Rosemary","year":"2016","unstructured":"Rosemary ME, Natalie T, Reema H, et al. Meta-analysis of the reasoned action approach (RAA) to understanding health behaviors. Ann Behav Med. 2016;50(4):592\u2013612.","journal-title":"Ann Behav Med"},{"issue":"7","key":"3139_CR30","first-page":"1779","volume":"56","author":"CK Pollard","year":"2015","unstructured":"Pollard CK, Mccourt EA, Zegar K, et al. Barriers to genetic testing in pediatric retinis pigmentosa. Invest Ophthalmol Vis Sci. 2015;56(7):1779.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3139_CR31","doi-asserted-by":"crossref","unstructured":"Ban CX, Xiao SF, Lin X et al. Clinicians\u2019 prescription preferences for treating patients with Alzheimer\u2019s disease in Shanghai. Transl Neurodegener Dis (English). 5(1):8.","DOI":"10.1186\/s40035-016-0055-3"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03139-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T06:03:52Z","timestamp":1678169032000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03139-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3139"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03139-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2398239\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]},"assertion":[{"value":"20 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was performed in accordance with the Declaration of Helsinki. Ethical considerations. This study was approved by the Research Ethics Committee of West China Medical Center of Sichuan University. All respondents provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}